Johnson & Johnson is a self-described global leader in the healthcare industry, providing a wide range of products and services.

Johnson & Johnson

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

Google Maps

Charles Prince

Mary Coleman

Anne Mulcahy

William Perez

Alex Gorsky

Mark Weinberger

Mary Beckerle

Susan Lindquist

Dominic J. Caruso

Vice President, Finance and Chief Financial Officer

Eric Milledge

Company Group Chairman

William E Cohn

VP, Medical Device Companies, Johnson & Johnson

Imran Rahim

Director, Information Security & Risk Management - AP

Jason Brown

Postdoctoral Fellow

Jorge Rowe

Sales Manager

Alice Lin Fabiano

Director, Worldwide Corporate Giving

Steve Wrenn

SVP & Group CIO Global Supply Chain

Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.

Dreem is a neurotechnology company composed of sleep pioneers, a team of experts fascinated by science, technology and design.

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Suncayr has developed a UV-responsive sticker that tells you when your sunscreen is no longer protecting you, using a simple colour change.

CardioMEMS develops wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body.

MicroMass Communications is a healthcare communications agency.

Crucell researches and develops products and markets vaccines, proteins and antibodies for the treatment of infectious diseases.

Ci:z Holdings develops, manufactures and sale of cosmetics.

New Jersey Companies With More Than $100M in Revenue

Health Care Public Companies

Health Care Companies With More Than $50M in Revenue (Top 10K)

Companies With More Than 1000 Employees (Top 10K)

Johnson & Johnson's research and development, manufacturing, and sale of healthcare products include pharmaceuticals, medical devices, and diagnostics. The company aims to improve access and create healthier communities.

New Brunswick

New Jersey

United States

North America

2 Dow Jones Dividend Stocks With Yields Above 3% You Can Buy Now and Hold at Least a Decade

Johnson & Johnson (JNJ) seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor

Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy Français

AI, Vitamin D, Teenage Pregnancy: The Week in Health

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll

Skin Care Products Market is likely to grow at a CAGR of 3.6% through 2031, reaching US$ 241.5 billion

Protagonist takes center stage with Phase III fillip

Thrombectomy Devices Market Size to be Worth USD 2.2 Billion by 2032, with a Projected CAGR of 7%

Cleanup for the IL-23 class in ulcerative colitis as new drugs 'rapidly gained significant momentum': report

Sector Update: Health Care Stocks Edge Lower Wednesday Afternoon

Johnson & Johnson's Innovative Medicine division focuses on developing treatments for complex diseases in areas such as oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina.

Johnson & Johnson MedTech provides medical technology solutions, focusing on interventional solutions, orthopaedics, surgery, and vision, with an emphasis on precision and less invasive treatments.

Johnson & Johnson offers cataract surgery solutions, including intraocular lenses like the TECNIS Odyssey IOL, which aim to restore vision and reduce the need for glasses.

Johnson & Johnson is involved in cell therapy research, aiming to harness the immune system to target and treat cancer.

Johnson & Johnson is researching treatments for prostate cancer, focusing on blocking cancer cells from repairing their damaged DNA.

Johnson & Johnson MedTech provides diagnostic and treatment solutions for atrial fibrillation, including mapping catheters and ablation technologies.

United Kingdom

Europe

India

Asia

Germany

Switzerland

HTML5

Modernizr

Apache Server

F5 NGINX

Bootstrap

Akamai Intelligent Platform

.NET 4.5

Google Doubleclick

ClearSlide

Johnson & Johnson owns Xian-Janssen Pharmaceutical

Johnson & Johnson owns Veridex

Johnson & Johnson owns Tibotec

Johnson & Johnson owns Therakos

Johnson & Johnson owns Scios Inc

Johnson & Johnson owns OraPharma Inc. (acquired by JNJ)

Johnson & Johnson owns Omrix Biopharmaceuticals

Johnson & Johnson owns Noramco

Johnson & Johnson owns Neutrogena

Johnson & Johnson owns Mentor Worldwide

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 17, 2024 5:00 AM	e4c20e16
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 17, 2024 5:00 AM	ce1998f9
crunchbase trigger	general	Nov 25, 2024 9:06 AM	51f283d4
crunchbase profile	general	Nov 25, 2024 10:37 AM	b497ce99
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 4:20 PM	0b5bb9a2
peers	general	Oct 17, 2024 5:00 AM	d618501f
news basic	general	Oct 17, 2024 5:00 AM	cf8812d2
bundesanzeiger	filings
financials download nd	financials
private financials	financials

IN:JNJ

Johnson & Johnson